TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Amber BioSciences AB
Closing information (x1000 SEK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
128
|
137
|
121 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
32
|
60
|
45 |
| EBITDA |
32
|
60
|
45 |
| Total assets |
1,266
|
1,239
|
1,237 |
| Current assets |
338
|
296
|
309 |
| Current liabilities |
0
|
22
|
70 |
| Equity capital |
364
|
338
|
0 |
| - share capital |
100
|
100
|
0 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
28.8%
|
27.3%
|
0% |
| Turnover per employee |
128
|
137
|
121 |
| Profit as a percentage of turnover |
25.0%
|
43.8%
|
37.2% |
| Return on assets (ROA) |
2.5%
|
4.8%
|
3.6% |
| Current ratio |
1345.5%
|
441.4% | |
| Return on equity (ROE) |
8.8%
|
17.8% | |
| Change turnover |
-9
|
16
|
15 |
| Change turnover % |
-7%
|
13%
|
14% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.